---
title: Publications
permalink: /singapore-myeloma-tumour-group/publications/
variant: tiptap
description: ""
---
<p><strong>The impact of upfront versus sequential use of bortezomib among patients with newly diagnosed multiple myeloma (MM): A joint analysis of the Singapore MM Study Group and the Korean MM Working Party for the Asian myeloma network. </strong>Please access the link: <a href="https://www.sciencedirect.com/science/article/abs/pii/S014521261300194X" rel="noopener noreferrer nofollow" target="_blank"><u>https://www.sciencedirect.com/science/article/abs/pii/S014521261300194X#</u></a></p><p><strong>Thrombotic microangiopathy during carfilzomib use: case series in Singapore. </strong>Please access the link: <a href="https://www.nature.com/articles/bcj201662" rel="noopener noreferrer nofollow" target="_blank"><u>https://www.nature.com/articles/bcj201662</u></a></p><p><strong>Vinorelbine-Cyclophosphamide compared to cyclophosphamide in peripheral blood stem cell mobilization for multiple myeloma. </strong><br>Please access the link: <a href="https://www.sciencedirect.com/science/article/pii/S1658387618300335" rel="noopener noreferrer nofollow" target="_blank"><u>https://www.sciencedirect.com/science/article/pii/S1658387618300335</u></a></p><p><strong>Role of Conventional Karyotyping in Multiple Myeloma in the Era of Modern Treatment and FISH Analysis. </strong><br>Please access the link: <a href="https://pubmed.ncbi.nlm.nih.gov/31171473/" rel="noopener noreferrer nofollow" target="_blank"><u>https://pubmed.ncbi.nlm.nih.gov/31171473/</u></a></p><p><strong>Natural History and Prognostic Factors at First Relapse in Multiple Myeloma. </strong>Please access the link: <a href="https://pubmed.ncbi.nlm.nih.gov/32630644/" rel="noopener noreferrer nofollow" target="_blank"><u>https://pubmed.ncbi.nlm.nih.gov/32630644/</u></a></p><p><strong>A phase 2 study of carfilzomib, cyclophosphamide and dexamethasone as frontline treatment for transplant-eligible MM with high-risk features (SGH-MM1). </strong><br>Please access the link: <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/34480015/" rel="noopener noreferrer nofollow" target="_blank"><u>https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/34480015/</u></a></p><p><strong>Early relapse post autologous transplant is a stronger predictor of survival compared with pretreatment patient factors in the novel agent era: analysis of the Singapore Multiple Myeloma Working Group. </strong><br>Please access the link: <a href="https://www.nature.com/articles/bmt201643" rel="noopener noreferrer nofollow" target="_blank"><u>https://www.nature.com/articles/bmt201643</u></a></p>